In the present study, as seen in Table 4, there are no notable differences between the CD36 variants and the number of fatalities during observation, fatalities due to cardiological reasons, instances of myocardial infarction within a ten-year observation period, hospitalizations for cardiovascular issues, all cardiovascular occurrences, and the number of months lived. This evidence concerns the gene CD36 and myocardial infarction.